Although our study contains many suggestions regarding the role of TOMM40 variation in cardiac conduction disease and MACE, the sample size may represent a limit; at the same time, our particular population, constituted of very high-risk old patients, may limit the result extension to the general population. This evidence concerns the gene TOMM40 and heart conduction disease.